A targeted prostate cancer screening programme could be possible in five years - what will it look like? 28 Jan 2022 The UK began screening for breast cancer nearly 35 years ago but we’re yet to have a screening programme for prostate cancer. Julia Bakker spoke to the UK’s leading expert in prostate cancer genetics, the ICR’s Professor Ros Eeles, about the progress we’re making and when we can expect prostate cancer screening to be a reality. Find out more Show/Hide
“I’m 33 years old, and there’s still so much I want to do” - Kate's story 06 Jul 2021 Kate Parker was diagnosed with stage 4 bowel cancer just before her 30th birthday. She tells us what more treatment options mean for her. Find out more Show/Hide
ASCO 2021: The science behind olaparib’s promise shown in the OlympiA early breast cancer trial 04 Jun 2021 The OlympiA trial results show the benefits of a targeted drug in patients with early-stage breast cancer and inherited BRCA mutations. We spoke to Chair of the OlympiA steering committee Professor Andrew Tutt about the landmark ICR research that underpins this major breakthrough. Find out more Show/Hide